Screening large “libraries” of compounds to find those with a desired biological activity is a powerful method for discovering new drugs, but requires a large, expensive and dedicated facility.
Now, scientists at the Florida campus of The Scripps Research Institute (TSRI) have devised the central component of a screening system that would be orders of magnitude smaller and cheaper.
“We’ve developed a device that can do the functional equivalent of high-throughput compound screening on an ultra-miniaturized scale,” said the study’s principal investigator Brian M. Paegel, an associate professor at TSRI.
The advance, published recently online ahead of print in Analytical Chemistry, follows a previous study from the Paegel laboratory in ACS Combinatorial Science that described the synthesis of miniaturized DNA-encoded compound libraries. The new screening device is designed to work with the new type of library.
Current high-throughput screening systems typically occupy 10,000 square feet of space or more and cost millions of dollars. They rely heavily on robotic devices that retrieve compounds from the library, place each compound into a separate small well in an “assay microplate” and measure each compound’s biological activity—for example, whether the compound inhibits a particular enzyme involved in viral replication.
Being almost entirely automated and relatively quick, such systems can rapidly screen the tens or hundreds of thousands of compounds in a typical library. But the great cost of these high-throughput screening systems limits their use to locations at pharmaceutical companies and large research institutions. The Scripps Florida campus houses one of the most active high-throughput screening facilities outside the pharmaceutical industry.
The new approach starts with the use of “one-bead-one-compound” (OBOC) libraries, in which individual compounds are chemically attached to microscopic beads. Over the past two decades, many laboratories have begun to work with OBOC libraries of one type or another, which are so quickly and cheaply prepared and are so compact that such libraries are essentially laboratory consumables.
“It is possible to generate an OBOC library of millions of compounds in a week for about $500,” said Alexander K. Price, a senior research associate in the Paegel laboratory and lead author of the new study.
There are considerable technical challenges involved in putting bead-borne compounds through miniature screening devices. But, as they report in their new paper, Paegel and Price were able to engineer a benchtop-scale device that meets these challenges and can screen OBOC libraries.
The device is built on the microfluidics principles that also underlie inkjet printer technology. Using a “suspension hopper,” which Paegel and Price described in a 2014 Analytical Chemistry paper, the device introduces OBOC library beads into tiny liquid droplets that contain the assay of interest, such as an enzymatic activity assay. The volume of these assay droplets is about 100,000 times less than the volumes used for high-throughput screening assays.
The device then frees each compound from its bead with a photochemical reaction induced by ultraviolet (UV) light and, after an appropriate period of incubation, records the result in each droplet.
Dubbed LIGHTSABR (Light-Induced and Graduated High-Throughput Screening After Bead Release) for its light-based cleavage of compounds from their carrier beads, the device overcomes significant technical hurdles concerning the smooth flow of droplets, the absorption of stray UV irradiation and calibration of the UV waveguide.
A key innovation is that the technique allows users to vary the UV illumination to adjust the amount of a compound cleaved from its bead—and thus adjust the dose of the compound being tested. The team successfully demonstrated this dosing function using an assay designed to find inhibitors of HIV-1 protease, a key enzyme involved in the replication of the virus that causes AIDS.
The next step for Paegel and Price is to apply the microfluidic LIGHTSABR and the laboratory’s DNA-encoded OBOC libraries. “In addition to antiviral compounds, we are also pursuing new antibiotics and other drug classes that address the emergence of resistance in rapidly evolving pathogens,” said Paegel.
“Hundreds of laboratories around the world could operate their own miniaturized screening facilities, using their own assays to go after targets that are of most interest to them,” said Price.
The Latest on: Portable Drug-Discovery System
via Google News
The Latest on: Portable Drug-Discovery System
- Tetra Bio-Pharma Provides Regulatory Update for Its CAUMZ(TM) Kiton October 3, 2019 at 5:30 am
The Mighty Medic device was selected because it has a robust quality system that adheres to the FDA’s quality system regulations ... is a biopharmaceutical leader in cannabinoid-based drug discovery ...
- Scientists enlist tiny biomagnets for faster drug discoveryon September 22, 2019 at 5:00 pm
A new platform brings together CRISPR genome editing with magnetic cell sorting to reveal new drug targets for cancer and regenerative medicine. What started as a hallway conversation between ...
- Workflow systems turn raw data into scientific knowledgeon September 2, 2019 at 5:03 am
Meyer’s team was using an in-house system called AWE, whereas Finn was working with ... But, says Brian Naughton, data lead and co-founder of the drug-discovery firm Hexagon Bio in Menlo Park, ...
- Alzheimer's Drug Discovery Foundation announces the first award recipients of its Diagnostics Accelerator Programon May 30, 2019 at 8:59 am
NEW YORK, NY, May 30, 2019 -The Alzheimer's Drug Discovery Foundation (ADDF ... may be offered for widespread use as a cloud-based system for analyzing retinal images or incorporated into the eye scan ...
- MIT Team Develops Portable Drug Production Systemon August 1, 2016 at 5:47 am
Scientists at MIT, with funding from the Defense Advanced Research Projects Agency (DARPA), say they have developed a portable production system designed to manufacture a range of biopharmaceuticals ...
- Researchers Develop 'LIGHTSABR'—a Cheap, Portable Drug-Discovery Systemon February 11, 2016 at 7:48 am
Paegel, an associate professor at TSRI. Current high-throughput screening systems typically occupy 10,000 square feet of space or more and cost millions of dollars. They rely heavily on robotic ...
- Scripps Florida Researchers Develop 'LIGHTSABR'-A Cheap, Portable Drug-Discovery Systemon February 10, 2016 at 1:50 pm
Now, scientists at the Florida campus of The Scripps Research Institute (TSRI) have devised the central component of a screening system that would be orders of magnitude smaller and cheaper. “We’ve ...
- Researchers develop 'LIGHTSABR'—a cheap, portable drug-discovery systemon February 9, 2016 at 4:00 pm
Now, scientists at the Florida campus of The Scripps Research Institute (TSRI) have devised the central component of a screening system that would be orders of magnitude smaller and cheaper. "We've ...
- Health Canada Approves Medical Device License for CARESTREAM DRX-Revolution Mobile X-Ray Systemon March 1, 2012 at 5:20 am
The DRX-Revolution can enhance image quality for portable exams thanks to its powerful ... molecular imaging systems for life science research and drug discovery/development; X-ray film and digital ...
- Saint Louis University Hospital Purchases 13 CARESTREAM DRX Systems To Improve Image Qualityon December 16, 2011 at 12:07 am
Saint Louis University Hospital, St. Louis ... a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for life science research and drug ...
via Bing News